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The interactions of chromium and proteins
have been studied by various investigators. By
tagging proteins with radioactive chromium, Grey
and Stirling (1) demonstrated that plasma pro-
teins bound trivalent chromium. Hexavalent
chromium combined with hemoglobin only after
reduction to the trivalent state. After undergoing
reduction hexavalent chromium also interfered
with nucleic acid determinations by combining
with proteins (2). With an electrophoretic technic,
no binding of hexavalent chromium to proteins
could be detected; binding was postulated if the
metal were converted to the trivalent form (3).
Baetjer, Damron and Budacz (4) investigated the
interactions of both tn- and hexavalent chromium
with lung tissue. They found that only trivalent
chromium was bound to the tissue; again hexa-
valent chromium had to undergo reduction to
the trivalent state before it could combine with
the lung tissue. Anderson (5) reported that skin,
when treated with either tn- or hexavalent
chromium bound considerable amounts to chro-
mium. The blocking of certain functional groups
in the skin had little effect on the amount of
chromium bound. In these studies the oxidation
state of the bound chromium was not determined;
it was assumed that in the course of the reaction
chromium remained in the original oxidation
state.
In subjects sensitive to chromates, hexavalent
chromium produces allergic eczematous derma-
titis. Although spectrographic examination of
biopsy specimens from positive patch test areas
failed to show chromium in the skin, the amounts
of chromium involved may have been beyond the
limits of detection (6). Schwarz and Spier (7)
propose that hexavalent chromium is reduced in
the skin to the trivalent state before it binds with
protein, and suggest that sulfhydryl groups effect
this reduction. Inactivation of sulfhydryl occurs
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during penetration of hexavalent chromium
through the skin (5). Mali (11) also proposes the
reduction of hexavalent chromium in the skin
with subsequent tissue albumin-globulin binding.
On the basis of current valence theory trivalent
chromium has a greater tendency to be bound to
the skin by covalent bonds than hexavalent
chromium. The chromic ion has the available
bonding orbitals to form coordination compounds
with the basic nitrogen, oxygen, sulfur atoms and
amino acids of the skin proteins; these orbitals
are absent in the hexavalent species. We believe
that in order for chromium to be found to the
skin, it must be reduced first and the resulting
trivalent chromium then combined with the skin.
The present investigation is an attempt to
study the chemical reactions between chromium
and skin and their possible role in allergic eczema-
tous contact-type dermatitis. The aims of this
study are (1) to study the reduction of hexa-
valent chromium by the skin, (2) to determine
which constituents of the skin are responsible
for this reduction, (3) to inVestigate the binding
of chromium to the skin, and (4) to determine
which skin constituents are able to bind chro-
mium. Such data may provide a basis for inter-
preting the combination of hapten with protein
in epidermal hypersensitivity.
I. THE REDUCTION OF JIEXAVALENT CHROMIUM
BY SKIN
To study the reduction of hexavalent chromium
by skin, samples of wet autopsy skin from the
lower abdomen were weighed in small flasks and
treated with measured amounts of aqueous potas-
sium diehromate solution containing 1.28 mg Cr
(VI)/5 ml. The flasks were then incubated for 48
hours at 37°. After this time, half of the samples
were analyzed for hexavalent chromium, the other
half for total chromium.t The results of this
study are presented in Table I.
The data obtained in this study show that the
skin has the ability to reduce hexavalent chro-
mium. An average of 1.06 mg of hexavalent chro-
mium was reduced by one gram of wet tissue.
35
t See Appendix I for analytical methods.
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TABLE I
The reduction of hexavalent chromium
by skin
(all samples initially contained 1.28
mg Cr(VI))
0.844
0.786
0.836
0.849
0.786
0.888
0.800
0.791
0.852
0.847
0.722
0.960
II. THE REDUCTION OF HEXAVALENT CHROMIUM
BY SKIN CONSTITUENTS
From a review of the composition of the stratum
disjunctum, this layer consists of 52—55% water-
insoluble material, 5—10% water, 10—22% ether
soluble material and 19—27% water soluble mate
rial. The distribution of the water-soluble material
is given as: 40% free amino acids, 10% carbohy-
drates, 1% citric acid, 12% lactic acid, 20% inor-
ganic compounds, 1% ammonia and nitrogen
compounds, 10% urea and 12% alpha pyrrolidon-
carbonic acid (9).
A. Amino Acids
First we studied the chromium reducing abil-
ities of the free amino acids of the stratum dis-
junctum (9) and of the barrier layer (10). Ten ml
aliquots of stock solntions (4 mg/ml) of amino
acids were transferred to 25 ml volumetric flasks
and mixed with 5 ml of a stock potassium dichro-
mate solution containing 10.0 mg Cr (VI) ml.
The solutions were brought to volume with a
phosphate buffer of pH 7, and the flasks were in-
cubated at 370 for 48 honrs. After this time, two 5
ml aliquots from each flask were analyzed for
hexavalent chromium.
In duplicate experiments, controls were ana-
lyzed to evaluate the effects of each amino acid
on the reliability of the analytical method. The
results agreed within 1%; when the accuracy of
the method was evaluated, the other values tended
to be low by 2.2% (Table II).
If the maximum error in the chromium analyses
is assumed to be 5% the results listed in Table II
t See Appendix I for analytical methods.
show that only methionine and cysteine can re-
duce hexavalent chromium, probably due to the
mild reducing ability of the divalent sulfur atom
in these amino acids. The apparent inertness of
cystine may be due to the disulfide linkage.
To study delayed reduction of chromium, the
chromium-amino acid solutions remaining after
the removal of the two aliquots for analysis were
transferred to small vials and stored in the dark
at room temperature (20—26°) for periods of 4 to
6 weeks. At the end of this period, 5 ml aliquots
were removed from each vial and analyzed for
hexavalent chromium.
The results of this study are listed in Table III.
If the maximum error in the chromium analyses
is again assumed to be 5%, the results show that
lysine, histidine, tryptophan, cystine, methionine
and cysteine have the ability to reduce hexavalent
chromium. The increased activity of cystine after
long standing is thought to be due to the slow
hydrolysis of the disulfide linkage to produce
sulfhydryl groups which are able to reduce the
hexavalent chromium. The delayed reducing
abilities of lysine, histidine and tryptophan can-
not be explained at present. As these amino acids
show no interactions with hexavalent chromium
within 48 hours, they are probably not involved in
TABLE II
The reduction of hexavalent chromium
by amino acids after 48 hours
(all systems initially contained 50.0
mg Cr(VI))
* Cysteine is not reported to be found free in
the skin.
Wet Skin g Total CrFound mg
1.28
1.28
1.28
1.29
1.29
1 .28
Cr (VI) Found
mg
0.43
0.47
0.44
0.37
0.46
0.27
Cr (VI)
Reduced
mg/g Skin
1 .06
1.03
0.98
1.08
1.14
1.05
Amonnt Cr (VI) Found
mg mgAmino Acid
arginine
histidine
lysine
tyrosine
tryptophan
phenylalanine
cystine
methionine
serine
threonine
leucine
isoleucine
glutamic acid
aspartic acid
glycine
alanine
proline
ornithine
citrulline
cysteine*
41.6
38.7
45.9
40.9
38.0
40.9
45.7
45.4
38.9
44.2
40.5
44.4
43.6
40.3
38.4
39.6
39.8
42.8
47.4
41.9
50.5, 50.5
48.8, 48.6
51.0, 50.7
47.3, 47.4
47.8, 47.5
49.2, 49.5
48.0, 47.8
44.8, 44.4
48.8, 48.7
48.0, 48.0
48.0, 48.6
48.5, 48.2
48.3, 48.5
49.3, 49.3
48.8, 48.6
49.5, 49.1
47.8, 48.0
48.5, 48.5
47.0, 47.5
40.3, 40.0
Difference
+1.0
—2.6
+1.8
—5.2
—4.8
—0.8
—4.2
—12.8
—2.4
—4.0
—3.4
—3.2
—3.2
—1.4
—2.6
—1.4
—4.2
—3.0
—5.2
—19.6
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TABLE III
The reduction of hexavalent chromium
by amino acids after 4 to 6 weeks
Amino Acid % of Cr(VI) Reduced
arginine 1.6
histidine 8.2
lysine 12.9
tyrosine 2.4
tryptophan 7.5
phenylalanine 3.0
cystine* 21.9
methionine 27.0
serine 4.0
threonine 2.8
leucine 2.4
isoleucine 1 .7
glutamic acid 2.2
aspartic acid 2.6
glycine 0.8
alanine 2.4
proline 3.6
ornithine 5.1
citrulline 1.7
cysteine* 353
found free in
allergic chromate reactions which appear shortly
after exposure to chromates.
B. Carbohydrates
To investigate the effects of carbohydrates on
the reduction of hexavalent chromium, 10 ml
aliquots of stock solutions of selected sugars (4
mg/mi) were transferred to 25 ml volumetric
flasks, mixed with 5 ml of the stock potassium
dichromate solution (10.0 mg Cr(VI)/ml), and
brought to volume with phosphate buffer of pH 7.
The flasks were incubated for 48 hours at 370•
After this time, the chromium remaining in the
hexavalent state was determined in two 5 ml
aliquots. The blank values needed to calculate the
amount of chromium were determined for each
sugar.
The results of this study are presented in Table
IV.
If the experimental error is assumed to be of the
order of 5%, the data in Table IV show little evi-
dence of reduction of hexavalent chromium by the
sugars studied.
C. Proteins
Aliquots of aqueous stock solutions of proteins
were transferred to volumetric flasks, mixed with
5 ml of the stock solutions of potassium dichro-
mate and diluted to 25 ml with phosphate buffer.
TABLE IV
Reduction of hexavalent chromium by
sugars
(all systems initially contained 50.0
mg Cr(VI))
Sugar
I
Amount
org Cr(VI) Found mg
Difference
%
lactose
dextrose
arabinose
levulose
maltose
galactose
sucrose
55.4
48.8
35.7
48.6
35.1
38.8
90.0
48.7, 48.5
48.8, 50.0
47.0, 47.0
46.6, 46.9
48.2, 48.3
48.5, 48.5
48.4, 48.3
—2.7
—2.0
—6.0
—6.5
—3.4
—3.0
—3.2
TABLE V
The reduction of hexavalent chromium
by proteins
(all systems initially contained 50.0
mg Cr(VI))
.
rotein Amount
mg
Cr(VI) Found
mg
Difference
%
gamma globulin
fibrinogen
gelatine
casein
serum albumin
hemoglobin
99
100
103
110
113
104
46.5, 45.9
47.7, 47.8
48.0, 49.0
50.0, 50.3
46.5, 47.5
41.8, 42.1
—7.6
—4.5
—3.0
+0.3
—6.0
—16.0
The test solutions were incubated for 48 hours at
37°, and after this time, the chromium remaining
in the hexavalent state was determined by analyz-
ing two 5 ml aliquots of each test solution. The
blank values needed to calculate the amount of
chromium remaining in the hexavalent state were
determined for each of the proteins studied.
The results of these experiments are presented
in Table V.
The high reducing ability of hemoglobin is in
agreement with the observations of Grey and
Stirling (1). There is little correlation between the
amount of divalent sulfur in gamma globulin and
the amount of chromium reduced. The amount of
hexavalent chromium reduced is larger by a factor
of 10 than could be expected on the basis of the
reducing abilities of the cystine and methionine
content of this protein.
D. Organic Acids
Aliquots of stock solutions of organic acids
were mixed with measured volumes of the stock
potassium dichromate solution. The resulting test
solutions were brought to a convenient volume
§ See Appendix I for analytical methods.
* Cysteine is not reported to be
the skin.
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TABLE VI
The reduction of hexavalent chromium
by organic acids
(all systems initially contained 50.0
mg Cr(VI))
Acid Amount
I mg
Cr(VI) FOUndDifierence
mg
citric 50.0 47.5, 47.9 —4.6
lactic 51.9 27.0, 27.8 —45.6
uric 45.8 48.8, 47.8 —3.4
pyroglutamic 47.3 55.4, 54.2 —9.6
with phosphate buffer and incubated at 37° for
48 hours. Analyses were done as described above.
The results of this study are listed in Table VI.
Assuming a maximum experimental error of 5%,
the data in Table VI show that lactic acid has
the ability to reduce considerable amounts of
hexavalent chromium.
In summary, of the many skin constituents
studied, the sulfur containing amino acids and
lactic acid were able to reduce hexavalent chro-
mium. In a group of selected proteins, hemoglobin
and gamma globulin also showed chromium re-
ducing abilities.
III. THE BINDING OF HEXAVALENT CHROMIUM
TO SKIN
Samples of wet surgical or autopsy skin were
freed of fat and weighed into test tubes and
treated with 5 ml of a potassium dichromate solu-
tion containing 10.0 mg of Cr (VI) ml and ap-
proximately 10 microCuries of radiochromate/ml.
The test tubes were stoppered and incubated at
37° for 48 hours. The skin samples then were
dialyzed for two weeks to remove the unbound
chromium. Blanks were included to demonstrate
the efficiency of the dialysis. After the dialysis
the amount of chromium bound to the skin was
determined in two ways; by classical chemical
analysis for both hexavalent and trivalent chro-
mium, and by a radiometric method for total
chromium. If
The results of this study are presented in
Table VII.
From the data presented in Table VII, it is
seen that the chromium bound to the skin is in
the trivalent form. This means that a chemical
reduction precedes the binding. Different skin
samples had different chromium binding capac-
ities. Mean values of 0.803 mg/gm were obtained
for abdominal skin and of 0.527 mg/gm for breast
skin. The binding of chromium by subcutaneous
fat was found to be negligible.
IV. THE BINDING OF REXAVALENT CHROMIUM
TO SKIN CONSTITUENTS
The binding of hexavalent chromium to skin
constituents was studied with the same substances
See Appendix II for radiometric methods.
TABLE VII
The binding of chromium to skin
(all samples incubated with 50 mg
Cr(VI))
Sam le
Num0ber Wet Skin
Cr (VI) Cr (III)
Found by Found by
Chem. Anal. Chem. Anal.
Total Cr
Found by
Radioactivity
g mg/g mg/g mg/g
Abdominal skin
52-1
52-2
52-4
52-6
60-2
60-4
60-5
60-8
3.010
2.665
2.290
1.856
0.890
1.272
1.012
0.816
0.001
0.000
0.000
0.000
*
0.793
0.797
0.808
0.752
0.819
0.816
0.844
0.792
Breast skin
82-1
82-2
82-3
82-4
82-5
82-6
82-7
1.259
1.659
1.029
1.313
1.534
0.826
1.210
0.005
0.006
0.005
0.007
0.006
0.001
0.006
0.668
0.329
0.411
0.529
0.395
0.504
0.700
0.706
0.351
0.442
0.586
0.435
0.570
0.697
Breast skin (subcutaneous fat removed)
c-26-8
c-26-9
c-26-10
c-26-11
c-26-12
c-26-13
c-26-14
c-54-1
c-54-3
c-54-4
c-54-6
c-54-7
c-54-8
c-54-9
c-54-10
1.237
1.558
1.302
1.222
1.585
2.104
1.340
0.485
0.536
0.627
0.567
0.771
0.856
0.473
0.461
*
0.000
0.000
0.001
0.001
0.000
0.001
0.000
0.000
0.541
0.431
0.566
0.570
0.467
0.412
0.650
0.622
0.430
0.489
0.588
0.475
0.524
0.505
0.592
0.693
0.390
0.463
0.633
0.417
0.490
0.493
0.627
* Samples not analyzed for hexavalent chro-
mium because amounts found in other samples
were not of analytical significance.
tested for reduction of hexavalent chromium.
These studies were carried out on small portions
of the original skin constituents by estimating the
amounts of bexavalent chromium remaining in
the test solutions after the reducing abilities were
evaluated. The binding of hexavalent chromium
was determined with spectrophotometric and
electrophoretic methods.
%
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FIG. 1
The absorption spectra for unbound trivalent
chromium and unbound hexavalent chromium
were recorded. The composite spectrum is pre-
sented in Figure 1.
The criteria for evaluating binding of chromium
were based on the assumption that characteristic
peaks of the species shift to other wavelengths
when binding takes place.
The binding of chromium was investigated for
each system by recording its spectrum against a
blank of the corresponding skin constituent and
comparing the wavelengths of the absorption
peaks with the composite spectrum of the free
chromium. The results of this study are presented
in Table VIII.
The spectrophotometric study did not indicate
any bound hexavalent chromium.
2. Electrophoretic Studies:
The use of the electrophoretic technique for
determining binding of chromium is based on the
assumption that the free skin constituents have
different mobilities in the electric field from those
combined with chromium.
Each system was studied with the method of
von Frijtag, et at (12) for the binding of chro-
mium. The electrophoretic patterns of amino
acids were developed with ninhydrin in acetone
and with diphenylcarbazide and acetic acid in
acetone to locate the hexavalent chromium. No
convenient method was available to identify the
trivalent chromium formed by the reduction of
the hexavalent chromium. Each amino acid-
chromium system was compared to the free amino
acid to determine differences which could be
attributed to the binding of chromium. The results
of this study are presented in Table IX.
The data in Table IX do not reveal the presence
of any amino acid-hexavalent chromium adduct.
TABLE VIII
Absorption spectra data for chromium
amino acid systems
V. THE BINDING OF TRIVALENT CHROMIUM
TO SKIN
The direct binding of trivalent chromium to the
skin was investigated by the same methods as
used for the hexavalent species. A stock Cr(III)
solution containing 10.0 mg Cr(III)/ml and 10
microCuries Cr5' (III)/ml was prepared by chem-
ical reduction of the hexavalent species. Spot tests
Absorption Spectrum
Free Cr and Cr
Wavelength.
1. Spectrophotometric Studies:
300
570
II
430
System
Cr (III)
Cr (VI)
arginine-Cr
histidine-Cr
lysine-Cr
tryptophan-Cr
tyrosine-Cr
phenylalanine-Cr
cystine-Cr
ornithine-Cr
methionine-Cr
serine-C r
threonine-Cr
leucine-Cr
isoleucine-Cr
glutamic acid-Cr
aspartic acid-Cr
glycine-Cr
alanine-Cr
proline-Cr
cysteine-Cr
citrulline-Cr
III IV
346 312
348 311
347 310
312
352 311
350 311
350 311
352 311
350 310
350 310
350 311
350 311
350 311
351 311
348 310
349 311
350 310
350 311
350 311
348 311
350 311
V
245
253
253
255
261
258
255
256
255
254
256
255
254
256
253
254
252
254
254
255
255
VI
230
230
234
233
236
238
231
231
230
231
232
231
232
232
230
231
230
230
230
232
232
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TABLE IX
Etectrophoretic data for amino acid
chromium systems
System
Control
Amino Arid
Migration
System M
Amino
igration
Cr(VI)
histidine-Cr )< )( 48+
arginine-Cr 23— 26— 56+
tyrosine-Cr X 1< 53+
lysine-Cr 34— 30— 55+
phenylalanine-Cr 7— 4— 53+
tryptophan-Cr X X 53+
methionine-Cr 12— 8— 49+
cystine-Cr X X 60+
threonine-Cr 0 0 48+
serine-Cr 11— 10— 49+
isoleucine-Cr 3+ 9— 47+
leucine-Cr 13— 6— 55+
glutamic acid-Cr 11+ 14+ 53+
aspartic acid-Cr X X 56+
alanine-Cr 8— 9— 54+
glycine-Cr 6— 8— 48+
proline-Cr X X 51+
ornithine-Cr 18— 25— 50+
cysteine-Cr X X 55+
citrullinc-Cr 0 2— 53+
with diphenylcarhazide indicated complete re-
duction (this test is sensitive to 0.25 pg Cr(VI)).
Weighed skin samples were incubated with meas-
ured volumes of the trivalent chromium solution,
dialyzed to remove the unbound chromium and
analyzed for bound chromium by radiometric
and chemical methods. The results of this study
are presented in Table X.
The data in Table X, when compared with the
data in Table VII, show that samples from the
same piece of skin bind more chromium when
treated with Cr(III) than when treated with
Cr(VI). Anderson's (5) data show the same trend.
However, our explanation for this phenomenon
differs from Anderson's, inasmuch as we think
that the skin binds only Cr (III), rather than
more Cr (III) than Cr (VI). In order for the skin
to bind chromium from solutions of hexavalent
chromium, a chemical reduction of the chromium
must take place. After hcxavalcnt chromium is
reduced by divalcnt sulfur in the skin, the result-
ing trivalent chromium is able to combine with
the skin constituents. Chemical analyses showed
no hexavalent chromium in the skin (Table VII).
No binding takes place in the subcutaneous fat.
Skin from which subcutaneous fat was removed
apparently bound more chromium from trivalent
chromium solutions than skin with subcutaneous
fat. In skin samples immersed in hexavalcnt chro-
mium solutions, the two factors regulating the
amounts of bound chromium are the number of
reducing sites and the number of binding sites
per gram of skin. Removal of subcutaneous fat
increases the number of both of these sites. Be-
cause the number of reducing sites is much smaller
than the number of binding sites, the removal of
subcutaneous fat had little effect on the binding
of chromium from solutions of hexavalent chro-
mium.
VI. THE BINDING OF TifiVALENT CHROMIUM
TO SKIN CONSTITUENTS
In this study, 5.0 ml of 0.10 M chromic nitrate
was mixed with 5.0 ml of 1.0 M amino acid solution.
The initial pH's of these solutions were in the
range of 1.5 to 2.0. The solutions were incubated at
37a for 48 hours and examined for color changes
due to complex formation. The solutions were
then stored in the dark for one week at room tem-
perature and the absorption spectra of diluted
aliquots were recorded. Gross changes in these
spectra when compared with those of chromic
nitrate solutions were attributed to complex f or-
mation or binding.
TABLE X
The binding of chromium to shin
(all samples incubated with 50 mg
Cr(III))
Sample Number Wet Skin
Cr Fouod
Chem. Analy-
sis
Cr Found
Radio. Analy-
sis
g mg/g ntg/g
Breast skin
82-11
82-12
82-13
82-14
82-15
82-16
82-17
c-26-1
c-26-2
c-26-3
c-26-4
c-26-5
c-26-6
c-26-7
c-54-11
c-54-12
c-54-13
c-54-14
c-54-16
c-54-17
c-54-18
c-54-19
c-54-20
1.261
1.037
0.910
1.211
0.950
0.822
1.472
1.315
0.861
1.503
1.111
1.981
1.003
1.319
0.655
0.430
0.697
0.836
0.550
0.632
0.424
0.391
0.406
1.13
0.972
0.790
1.16
0.930
2.46
0.470
2.50
2.58
2.09
2.80
2.24
2.52
2.44
2.46
2.22
2.22
2.18
2.10
2.66
2.58
2.65
2.60
0.890
0.916
0.862
0.837
0.875
2.30
1.05
2.00
2.10
1.96
2.21
1.78
1.75
2.06
3.56
2.03
2.12
2.02
2.29
2.71
2.69
2.84
2.58
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TABLE XI
Absorption spectra data for trivalent
chromium amino acid systems
System Color I II R*
Cr3 blue 570 404 1.01
Cr3 + lysine blue 572 404 0.975
Cr3 + methionine purple 558 408 0.850
Cr3 + tryptophan blue 568 404 0.984
Cr3 + aspartic acid purple 550 402 0.776
Cr3 + tyrosine blue 570 404 0.974
Cr3 + phenylalanine purple 560 404 0.875
Cr3 + histidine purple 560 404 0.926
Cr3 + glycine blue 570 404 0.950
Cr3 + isoleucine purple 558 404 0.850
Cr3 + proline blue 562 406 0.755
Cr3 + arginine blue 568 404 0.967
Cr3 + cystine blue 568 404 0.940
Cr3 + threonine purple 558 404 0.840
Cr3 + ornithine purple 560 404 0.883
Cr3 + alanine blue 562 400 0.917
Cr3 + norvaline purple 558 404 0.820
Cr3 + citrulline blue 558 404 0.882
Cr3 + glutamic acid green 568 412 0.744
Cr3 + leucine blue 566 406 0.865
Cr3 blue 570 404 0.982
The results of this
Table XI.
study are presented in
The data in Table XI show that several systems
contained Cr(III)-amino acid complexes asjudged from the shift of the 570 absorption peak
to shorter wavelengths. This shift is accompanied
by a color change from blue to purple and by a
marked change in the ratio of the absorbence at
570 to the absorbence at 404. To evaluate these
data, a parameter, R* was defined (13).
A of Cr (111)-amino acid system at 570
R* = A of Cr (111)-amino acid system at 404
A of Cr (III) at 570
A of Cr (III) at 404
When no complexing takes place, R* should
have a value of unity. Actually we found it to
range from 0.982 to 1.01. In evaluating these data,
we assumed that R* values differing from unity
by more than 0.05 indicated complex formation.
By these criteria, Cr (III) complexes are formed
with methionine, aspartic acid, phenylalanine,
histidine, isoleucine, proline, cystine, threonine,
ornithine, alanine, norvaline, citrulline, glutamic
acid and leucine.
COMMENT
The mechanism of epidermal sensitivity is still
obscure. In this study, we have directed our
attention to the antigen. Landsteiner and Jacobs
(14, 15) suggested that every antigen has two
chemical or physical aspects, namely, the hap-
tenic portion and the protein schiepper portion,
"protigen" (16). It has been reasonably well
established that simple chemicals which elicit
this type of reaction first conjugate with a body
protein. Eisen and his co-workers (17, 18, 19)
have described the chemical reaction of simple
compounds such as 2 :4 dinitrobenzenes (DNB)
in the elicitation of allergic contact dermatitis in
guinea pigs and in man. 2:4 dinitrofluorobenzene
(DNFB) combines chemically with skin con-
stituents such as the epsilon-amino groups of
lysine and the sulfhydryl groups of cysteine.
With lysine, the halogen radical of the DNB is
displaced and the NH2 group of the amino acid
conjugates with the benzene group. The body
reacts to this conjugated protein. In all likeli-
hood, the specificity of the reaction is primarily
determined by the haptenic portion of the mole-
cule, namely, the simple chemical; however, the
carrier or "protigen" necessary to make the
complex antigen, need not be inert and may be
the immunological determinant.
In the case of chromium several possibilities
may exist:
(1) The hexavalent chromium compound
unites with a skin protein to form a con-
jugate.
(2) The hexavalent chromium compound is
reduced in the skin to the Cr(III) form
and the latter combines with a protein to
form a conjugate.
(3) In the process of reduction, simultaneous
oxidation takes place and this oxidized or
altered protein is the antigen.
(4) The trivalent chromium compound can
become chelated and may form a strong
complex with protein.
(5) Chromium conjugates can be formed with
proteins not derived from the skin.
In our experiments we could not demonstrate
the binding of hexavalent chromium to skin or to
skin constituents. This eliminates hypothesis (1).
We were able to demonstrate the reduction of
Cr(VI) by skin and by certain skin constituents.
However, Cr(III) is not the hapten, let alone the
antigen, because in previous clinical studies (20)
we have reported that trivalent chromium com-
pounds were unable to sensitize patients with
dichromate sensitivity and there was no evidence
of cross-sensitization. In our experiments, chro-
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mium could be bound to skin only after being
reduced to the Cr(III) form. As yet, the nature
of this conjugate has not been defined. It seems
reasonable to assume that a biochemical altera-
tion, presumably an interference with some en-
zyme system, may reside in the altered protein
itself. It is possible that the oxidized protein,
containing the amino acid which has caused
reduction of Cr(VI) to Cr(III), in itself becomes
antigenically distinct from the parent protein.
Possibly the "disulfide bridges" of certain pro-
teins are broken by the interactions with hexa-
valent chromium and the resulting protein frac-
tions have antigenic properties. Furthermore,
certain heavy metal ions seem to have a particu-
lar affinity for certain tissues or proteins and may
act by denaturing proteins and inactivating
enzymes. The denaturation of blood plasma
albumin by chromium salts was demonstrated
by Clark (21). In a previous study (8) we de-
scribed the inactivation of epidermal-Sil groups
by chromium salts which may be responsible for
inactivation of enzymes. The exact role of the
chromium ion in the development of an antigen
remains to be defined; our work may be a step
toward resolving some of the many unanswered
problems.
CONCLUSION
Hexavalent chromium is reduced by skin. Of
the skin constituents investigated, the sulfur-con-
taining amino acids; methionine, cystine and
cysteine were able to cause this reduction. Lactic
acid also was able to reduce hexavalent chro-
mium. From a group of selected proteins, hemo-
globin and gamma globulin exhibited chromium-
reducing abilities.
The binding of chromium to skin was demon-
strated by chemical and radioactive tracer
methods. The chromium bound to the skin was
in the trivalent state, indicating a chemical
reduction of the hexavalent species before bind-
ing. With spectrophotometric and electrophoretie
technics, no hexavalent chromium complexes or
adducts with skin constituents could be found.
Compounds of trivalent chromium with methio-
nine, asparatic acid, phenyl alanine, histidine,
isoleucine, proline, cystine, threonine, ornithine,
alanine, morvaline, citrulline, glutamie acid and
leueine were detected by speetrophotometry.
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